HDM1002
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for HDM1002, covering 2024-07-15 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin [Phase 1]